14 Bioorthogonal Strategies for the Uncaging and Assembly of Drugs

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The bioorthogonal synthesis of drugs offers a unique opportunity for targeting — either molecularly, spatiotemporally or both — the delivery of active compounds directly to the disease site. Problems such as unfavorable pharmacokinetic (PK) profiles and dose-limiting side effects can be mitigated with the careful deployment of the tools of biorthogonal chemistry. In order to access medicinal applications, researchers have developed groundbreaking new chemistries for the caging and uncaging, assembly, and molecular targeting of a wide range of clinically approved drugs. This review presents notable examples of bioorthogonal drug synthesis that have emerged from the two main branches of the bioorthogonal field: organic click chemistries and transition-metal-catalyzed reaction
Original languageEnglish
Title of host publicationAbiotic Reactions in Live Environments
EditorsJ. L. Mascareñas, M. Tomás-Gamasa
PublisherGeorg Thieme Verlag KG
ISBN (Electronic)9783132458277
DOIs
Publication statusPublished - 2 Oct 2024

Keywords / Materials (for Non-textual outputs)

  • bioorthogonal catalysis
  • click chemistry
  • click-to-release
  • transition metals
  • prodrug
  • chemotherapy
  • targeted therapy

Fingerprint

Dive into the research topics of '14 Bioorthogonal Strategies for the Uncaging and Assembly of Drugs'. Together they form a unique fingerprint.

Cite this